TD Private Client Wealth LLC

SEC CIK: 0001551017
Latest filing: Aug 4, 2026

SEC filings (opens in a new tab)

TMO holding history

Thermo Fisher Scientific Inc. in every 13F filed by TD Private Client Wealth LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TMO overview All 13F holders of TMO Full Q2 2026 holdings

Shares (Q2 2026): 10,103
Value: $5.07M
% of portfolio: 0.1%
Quarters held: 22; Since Q1 2021

Holdings of TMO by TD Private Client Wealth LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	10,103	$5.07M	0.1%	−297−2.9%	Reduced	Holders
Q1 2026	10,400	$5.11M	0.1%	+870+9.1%	Added	Holders
Q4 2025	9,530	$5.52M	0.1%	+4,505+89.7%	Added	Holders
Q3 2025	5,025	$2.44M	0.1%	+187+3.9%	Added	Holders
Q2 2025	4,838	$1.96M	<0.1%	−2,712−35.9%	Reduced	Holders
Q1 2025	7,550	$3.76M	0.1%	+1,332+21.4%	Added	Holders
Q4 2024	6,218	$3.23M	0.1%	−1,931−23.7%	Reduced	Holders
Q3 2024	8,149	$5.04M	0.1%	+1,591+24.3%	Added	Holders
Q2 2024	6,558	$3.63M	0.1%	+167+2.6%	Added	Holders
Q1 2024	6,391	$3.71M	0.1%	+369+6.1%	Added	Holders
Q4 2023	6,022	$3.20M	0.1%	−475−7.3%	Reduced	Holders
Q3 2023	6,497	$3.29M	0.1%	−2,444−27.3%	Reduced	Holders
Q2 2023	8,941	$4.66M	0.2%	−2,268−20.2%	Reduced	Holders
Q1 2023	11,209	$6.46M	0.3%	−1,394−11.1%	Reduced	Holders
Q4 2022	12,603	$6.97M	0.3%	−2,604−17.1%	Reduced	Holders
Q3 2022	15,207	$7.73M	0.4%	+366+2.5%	Added	Holders
Q2 2022	14,841	$8.08M	0.4%	−416−2.7%	Reduced	Holders
Q1 2022	15,257	$9.02M	0.4%	+551+3.7%	Added	Holders
Q4 2021	14,706	$9.81M	0.4%	−4,505−23.5%	Reduced	Holders
Q3 2021	19,211	$11.0M	0.5%	−873−4.3%	Reduced	Holders
Q2 2021	20,084	$10.1M	0.4%	−2,172−9.8%	Reduced	Holders
Q1 2021	22,256	$10.2M	0.5%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.